R&D News | pharmaphorum

News

In another signal of the deepening relationship between the pharma and AI sectors, Novartis CEO Vas Narasimhan has joined the board of Anthropic.

News

Infectious disease experts from around the world are calling for concerted action to combat a "silent surge" in resistance to antifungal drugs.

News

A new R&D project will try to develop assays for LRRK2, a biomarker linked to Parkinson's that has emerged as a major drug target in the disease.

News

Amazon has pitched an AI-powered drug discovery platform to the biopharma industry that combines in silico and wet-lab work in a single application.

News

The FDA has launched a drive to get clinical trial sponsors to disclose the results of studies – even if they are negative.

News

Seeking an R&D edge, Novo Nordisk has become the latest big pharma group to forge an alliance with tech giant OpenAI.